Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7]
- PMID: 37495438
- DOI: 10.1016/j.ajog.2023.07.011
Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7]
Erratum for
-
Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use.Am J Obstet Gynecol. 2022 Dec;227(6):871.e1-871.e7. doi: 10.1016/j.ajog.2022.05.022. Epub 2022 May 13. Am J Obstet Gynecol. 2022. PMID: 35569516